Martingale Asset Management L P Regeneron Pharmaceuticals, Inc. Transaction History

Martingale Asset Management L P

$4.27 Billion
Q3 2024

A detailed history of Martingale Asset Management L P transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 21,711 shares of REGN stock, worth $15.7 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

21,711

Previous 26,183 17.08%

Holding current value

$15.7 Million

Previous $27.5 Million 17.06%

% of portfolio

0.53%

Previous 0.6%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $4.58 Million - $5.37 Million	-4,472 Reduced 17.08%	21,711 $22.8 Million
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $2.9 Million - $3.51 Million	-3,279 Reduced 11.13%	26,183 $27.5 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $3 Million - $3.3 Million	-3,320 Reduced 10.13%	29,462 $28.4 Million
Q4 2023 Feb 12, 2024	SELL	$775.18 - $881.7 $1.14 Million - $1.3 Million	-1,473 Reduced 4.3%	32,782 $28.8 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $1.45 Million - $1.77 Million	-2,097 Reduced 5.77%	34,255 $28.2 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $1.4 Million - $1.66 Million	-2,000 Reduced 5.21%	36,352 $26.1 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $358,618 - $435,813	-527 Reduced 1.36%	38,352 $31.5 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $2.56 Million - $2.78 Million	-3,627 Reduced 8.53%	38,879 $28.1 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $1.05 Million - $1.32 Million	-1,829 Reduced 4.13%	42,506 $29.3 Million
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $1.94 Million - $2.62 Million	-3,545 Reduced 7.4%	44,335 $26.2 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $2.04 Million - $2.39 Million	-3,422 Reduced 6.67%	47,880 $33.4 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $1.66 Million - $2.05 Million	-3,054 Reduced 5.62%	51,302 $32.4 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $6.21 Million - $7.36 Million	-10,813 Reduced 16.59%	54,356 $32.9 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $1.51 Million - $1.78 Million	-3,192 Reduced 4.67%	65,169 $36.4 Million
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $2.01 Million - $2.47 Million	4,498 Added 7.04%	68,361 $32.3 Million
Q4 2020 Feb 10, 2021	BUY	$478.3 - $607.98 $5.13 Million - $6.52 Million	10,729 Added 20.19%	63,863 $30.9 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $7.05 Million - $8.52 Million	12,946 Added 32.21%	53,134 $29.7 Million
Q2 2020 Aug 10, 2020	BUY	$493.32 - $643.92 $19.8 Million - $25.9 Million	40,188 New	40,188 $25.1 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $356,318 - $414,862	-1,303 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $299 - $414	-1 Reduced 0.08%	1,303 $0
Q1 2019 May 08, 2019	BUY	$372.08 - $439.57 $485,192 - $573,199	1,304 New	1,304 $0
Q1 2018 May 11, 2018	SELL	$315.82 - $393.78 $190,439 - $237,449	-603 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$358.63 - $469.95 $215,178 - $281,970	-600 Reduced 49.88%	603 $0
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $518,950 - $606,312	1,203	1,203 $538,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Regeneron Pharmaceuticals, Inc. Transaction History